Introduction#
Revvity, Inc. (RVTY has demonstrated a nuanced financial trajectory as it navigates recent operational challenges and strategic shifts. The company's stock price modestly increased by +0.33% to $86.74, reflecting investor attention on its evolving fundamentals and upcoming earnings announcement scheduled for November 3, 2025. Despite relatively flat revenue growth, significant changes in profitability and cash flow metrics warrant a detailed examination to understand the company's current financial health and strategic positioning.
Professional Market Analysis Platform
Make informed decisions with institutional-grade data. Track what Congress, whales, and top investors are buying.
Financial Performance Overview#
Revvity's fiscal year 2024 revenue remained virtually flat at $2.76 billion, a slight increase of +0.16% compared to 2023 ($2.75 billion), signaling a stabilization after prior declines. However, net income experienced a sharp contraction, falling by -60.99% to $270.38 million in 2024 from $693.09 million in 2023, reflecting margin pressures and elevated operating expenses. Earnings per share (EPS) followed a similar trend, declining by -60.36%.
More company-news-RVTY Posts
Revvity, Inc. Q2 2025 Analysis: Navigating China DRG Policy Headwinds and Strategic Growth
Explore Revvity's Q2 2025 performance amid China DRG policy challenges, strategic innovation efforts, and financial trends shaping RVTY stock's outlook.
Revvity, Inc. Q2 2025 Analysis: Navigating China Diagnostics Challenges and Life Sciences Growth
Explore Revvity's Q2 2025 earnings beat, China diagnostics headwinds, margin pressures, and strategic initiatives shaping its future growth trajectory.
Revvity, Inc. Latest Q2 2025 Earnings Analysis: Strategic Resilience Amid Biotech Challenges
Revvity's Q2 2025 earnings reveal strategic resilience with steady revenue growth, EPS beat, and innovation in diagnostics and drug discovery software.
The gross profit margin contracted to 55.81% in 2024 from 55.98% in 2023, continuing a downward trend from 60.08% in 2022 and 63.59% in 2021. Operating income margin also decreased to 12.59% in 2024 from 10.93% in 2023, after higher historical margins (22.43% in 2022 and 32.88% in 2021). These shifts reflect increased cost of revenue and selling, general and administrative (SG&A) expenses, which rose to $994.07 million in 2024, offsetting gains from revenue.
Profitability Table#
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue (USD Billion) | 2.76 | 2.75 | 3.31 | 3.83 |
Net Income (USD Million) | 270.38 | 693.09 | 569.18 | 943.16 |
Gross Margin (%) | 55.81 | 55.98 | 60.08 | 63.59 |
Operating Margin (%) | 12.59 | 10.93 | 22.43 | 32.88 |
Net Margin (%) | 9.81 | 25.20 | 17.19 | 24.64 |
Source: Monexa AI
Cash Flow and Capital Allocation#
Revvity's cash flow dynamics provide critical insights into its operational efficiency and capital management. Free cash flow surged dramatically by +5369.01% year-over-year to $541.65 million in 2024 from a mere $9.9 million in 2023. This rebound stems from a substantial increase in net cash provided by operating activities (+588.38%) to $628.3 million.
Capital expenditures remained stable at approximately $86.65 million, reflecting consistent investment in property, plant, and equipment. Meanwhile, financing activities showed significant outflows totaling $1.13 billion, primarily driven by stock repurchases of $369.58 million and dividend payments of $34.45 million. This capital return strategy underscores management's commitment to shareholder value despite recent earnings pressure.
Cash Flow Summary Table#
Metric | 2024 (USD Million) | 2023 (USD Million) |
---|---|---|
Net Cash Provided by Operating Activities | 628.3 | 91.27 |
Free Cash Flow | 541.65 | 9.9 |
Capital Expenditure | (86.65) | (81.37) |
Dividends Paid | (34.45) | (34.97) |
Common Stock Repurchased | (369.58) | (388.88) |
Source: Monexa AI
Balance Sheet and Financial Health#
Revvity’s balance sheet reflects cautious financial management amid a changing market environment. Total assets decreased to $12.39 billion in 2024 from $13.56 billion in 2023, primarily due to reductions in goodwill and intangible assets ($9.1 billion vs. $9.56 billion). Total liabilities also declined to $4.73 billion from $5.69 billion, largely driven by lower current liabilities and debt reduction.
The company's net debt improved significantly to $2.16 billion in 2024 from $3.15 billion in 2023, enhancing financial flexibility. The current ratio remains strong at 3.33x, indicating ample short-term liquidity. Debt-to-equity ratio at 0.45x (or 44.66%) suggests moderate leverage, manageable within the industry context.
Market Position and Competitive Context#
Revvity operates in a competitive landscape where innovation and cost efficiency are critical. The company's steady revenue but declining profitability metrics highlight challenges from market pressures and operational costs. Management’s active stock repurchase and dividend payments suggest confidence in the business’s long-term value despite near-term margin compression.
Industry peers have shown mixed results, with some competitors investing heavily in R&D to drive growth. Revvity’s research and development expenses amounted to $196.84 million in 2024, representing 7.33% of revenue, slightly below the industry expectation for firms prioritizing innovation-led growth.
Forward-Looking Financial Estimates#
Analyst consensus projects gradual recovery and growth for Revvity. Revenue is expected to rise at a compound annual growth rate (CAGR) of approximately 4.89%, with EPS growth forecasted at 8.72% over the coming years. Forward P/E ratios decline from 16.84x in 2025 to 12.06x in 2029, signaling anticipated margin improvement and earnings growth.
Year | Estimated Revenue (Billion USD) | Estimated EPS | Forward P/E |
---|---|---|---|
2025 | 2.85 | 4.87 | 16.84 |
2026 | 2.98 | 5.38 | 15.27 |
2027 | 3.16 | 6.02 | 12.79 |
2028 | 3.35 | 6.46 | 12.69 |
2029 | 3.45 | 6.80 | 12.06 |
Source: Monexa AI
What Drives Revvity’s Dividend Sustainability?#
Revvity currently offers a modest dividend yield of 0.32%, with a payout ratio of 11.88%, indicating conservative dividend payments relative to earnings. The company has maintained a stable quarterly dividend of $0.07 per share throughout 2025, reflecting a cautious but consistent approach to returning capital to shareholders.
The sustainability of this dividend is supported by robust free cash flow generation and a strong balance sheet, though earnings volatility and margin pressures could temper future increases. Investors seeking dividend growth should monitor profitability recovery and cash flow trends closely.
Key Takeaways#
- Revvity's revenue stabilized in 2024 with a modest +0.16% increase, but net income declined sharply by -60.99%, highlighting margin pressures.
- Free cash flow surged by over +5000%, driven by improved operating cash flow, enabling significant stock repurchases and dividend payments.
- Balance sheet strength improved with reduced net debt and a strong current ratio of 3.33x, enhancing financial flexibility.
- Forward estimates indicate gradual revenue and EPS growth with improving valuation multiples, suggesting recovery potential.
- Dividend payments remain conservative and sustainable, supported by strong cash flow despite earnings fluctuations.
What This Means For Investors#
Investors in RVTY should weigh the company's mixed financial signals carefully. While operational profitability has been under pressure, the substantial improvement in cash flow and disciplined capital allocation reflect management’s efforts to optimize shareholder value. The strong balance sheet provides a buffer for strategic investments and potential market shifts.
The forward-looking estimates offer a cautiously optimistic outlook, with expected growth in revenue and earnings over the next five years. However, investors should monitor ongoing margin trends and R&D investment levels, as these will be key drivers of long-term competitive positioning.
In summary, Revvity’s latest financial and strategic developments portray a company balancing near-term challenges with a pathway toward recovery and sustainable shareholder returns. This nuanced profile requires attentive analysis as the company approaches its next earnings release.
Sources:
- Monexa AI financial data
- Bloomberg for sector and competitive context
- Industry financial benchmarks from Market Analysis Reports